Hosted on MSN46m
Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A DealsPfizer PFE issued its financial guidance for 2025. Sanofi SNY and Teva Pharmaceutical’s TEVA inflammatory bowel disease (IBD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback